Ekhagastiftelsen Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2000
NCT00894816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now